Position in CRNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$49,394,400
-$6,901,600 QoQ
Shares Held
1,320,000
-14.8% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
2.88%
of 13F equity value
Holder Rank
#24
of 266 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NOVO HOLDINGS A/S holds $1,241,938,796 across 18 Biotechnology names. CRNX ranks #8 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
5,350,000 | $217,370,500 | |
| 2 | COAG |
Hemab Therapeutics Holdings, Inc.
|
4,180,550 | $153,551,601 | |
| 3 | MPLT |
MapLight Therapeutics, Inc.
|
3,686,622 | $132,128,532 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,125,000 | $131,703,750 | |
| 5 | AVLN |
Avalyn Pharma Inc.
|
3,883,289 | $127,837,873 | |
| 6 | AVBP |
ArriVent BioPharma, Inc.
|
1,500,000 | $52,110,000 | |
| 7 | ELVN |
Enliven Therapeutics, Inc.
|
1,000,000 | $50,750,000 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
This page
|
1,320,000 | $49,394,400 |
All Filings in CRNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,394,400 | 1,320,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $56,296,000 | 1,550,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $75,643,750 | 1,625,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $67,681,250 | 1,625,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $44,578,000 | 1,550,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $42,763,500 | 1,275,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $49,095,792 | 960,215 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $51,100,000 | 1,000,000 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $44,790,000 | 1,000,000 | Shares | Sole | 2024-08-20 | |
| 2024-03-31 | $51,425,466 | 1,098,600 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $39,138,000 | 1,100,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $32,714,000 | 1,100,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,822,000 | 1,100,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,666,000 | 1,100,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $13,488,143 | 737,057 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,405,154 | 631,627 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,779,843 | 631,627 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,326,489 | 424,897 | Shares | Sole | 2022-05-27 | |
| 2021-03-31 | $4,146,655 | 271,378 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,829,143 | 271,378 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,252,493 | 271,378 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,757,216 | 214,453 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,417,459 | 164,453 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||